BridgeBio Pharma Inc. (BBIO)
37.06
0.26 (0.69%)
At close: Feb 21, 2025, 3:43 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -543.35M | -643.2M | -484.65M | -586.45M | -505.49M | -288.58M | -169.45M | -43.83M |
| Depreciation & Amortization | 6.08M | 6.49M | 6.77M | 5.84M | 3.09M | 859K | 245K | 260K |
| Stock-Based Compensation | 95.8M | n/a | 91.56M | 99.5M | 58.46M | 21.37M | 6.07M | 1.84M |
| Other Working Capital | n/a | -13.05M | 28.43M | -7.23M | 15.67M | -6.26M | 5.79M | -334K |
| Other Non-Cash Items | -79.25M | 103.93M | -61.25M | 18.5M | 31.16M | 24.54M | 18.89M | 260K |
| Deferred Income Tax | n/a | n/a | n/a | -30.93M | -1.87M | -859K | -14.89M | -260K |
| Change in Working Capital | n/a | 5.06M | 28.08M | -4.4M | 14.93M | -10.91M | 22.49M | 1.24M |
| Operating Cash Flow | -520.73M | -527.72M | -419.49M | -497.93M | -399.71M | -253.59M | -136.64M | -40.49M |
| Capital Expenditures | -933K | -1.31M | -6.32M | -48.25M | -7.52M | -5.14M | -18.18M | -464K |
| Acquisitions | n/a | n/a | 120M | -35M | 21.24M | -5.49M | -2.86M | 2.84M |
| Purchase of Investments | -88.4M | -137.26M | -193.06M | -643.27M | -287.85M | -212.9M | n/a | n/a |
| Sales Maturities Of Investments | 158.23M | 193.11M | 532.52M | 477.04M | 242.23M | 5.49M | n/a | n/a |
| Other Investing Acitivies | -8.12M | -503K | 120M | 48.65M | -21.09M | 784K | -2.86M | n/a |
| Investing Cash Flow | 60.78M | 54.03M | 453.15M | -200.83M | -52.99M | -217.25M | -21.04M | -464K |
| Debt Repayment | n/a | n/a | -20.49M | 1.08B | 550M | 36.94M | 56.38M | 4.13M |
| Common Stock Repurchased | n/a | -6.88M | -1.56M | -204.75M | -75.71M | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | -997K | n/a | -1.15M |
| Other Financial Acitivies | 748.46M | 8.61M | 4.06M | -138.49M | -27.1M | -4.38M | 349.63M | 108.85M |
| Financial Cash Flow | 748.46M | 451.54M | -13.13M | 736.45M | 447.19M | 398.79M | 501.55M | 112.98M |
| Net Cash Flow | 288.51M | -22.15M | 20.52M | 37.69M | -5.52M | -72.05M | 343.87M | 72.03M |
| Free Cash Flow | -521.66M | -529.03M | -425.81M | -546.18M | -407.23M | -258.73M | -154.82M | -40.95M |